Cyto-Facto - Crunchbase Company Profile & Funding

Q: Where is Cyto-Facto's headquarters?

Cyto-Facto is located in Minamimachi, Tokyo, Japan.

Q: Who invested in Cyto-Facto?

Cyto-Facto has 7 investors including SMBC Venture Capital And D3.

Q: When was the last funding round for Cyto-Facto?

Cyto-Facto closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Cyto-Facto raised to date?

Cyto-Facto has raised obfuscated.

Overview

Cyto-Facto

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Cyto-Facto

CB Rank

116976

Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.

Founded

obfuscation

Private

Series A

Minamimachi, Tokyo, Japan

51-100

www.cytofacto.com/

Biotechnology

Manufacturing

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Details

Legal Name

Cyto-Facto Inc.

Operating Status

Active

Company Type

For Profit

About the Company

Cyto-Facto specializes in the contract development and manufacturing of cell and gene therapy products. The company offers services encompassing process development, GMP manufacturing, and quality control testing. Their digital platform enhances manufacturing efficiency through RFID tracking and paperless operations.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Contract Development and Manufacturing Organization (CDMO) Services for Gene and Cell Therapies

Provides contract manufacturing services for gene and cell therapy products, including process development and commercial production under GMP standards.

Quality Control Testing Services

Conducts quality control testing for gene and cell therapy products in compliance with Japanese Pharmacopoeia and GMP/GCTP standards.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A
obfuscated obfuscation	Series A - Cyto-Facto	7	obfuscated obfuscation	D3, MPower Partners	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
SMBC Venture Capital	—	Series A - Cyto-Facto	—
SMBC Venture Capital	—	Series A - Cyto-Facto	—
SMBC Venture Capital	—	Series A - Cyto-Facto	—
SMBC Venture Capital	—	Series A - Cyto-Facto	—
SMBC Venture Capital	—	Series A - Cyto-Facto	—